FDA Inspection 1280024 — Paul R. Harmatz, M.D.
The FDA completed an inspection of Paul R. Harmatz, M.D. on August 21, 2025 in Oakland, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 21, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Oakland, CA (United States)
Additional Details
Clinical Investigator (CI)